Melanoma-Specific Antigen-Associated Antitumor Antibody Reactivity as an Immune-Related Biomarker for Targeted Immunotherapies

Researchers applied the next generation phage display mimotope variation analysis to profile antibody response and dissected the role of humoral immunity in targeted cancer therapies, namely anti-tumor dendritic cell vaccine and immunotherapy with anti-PD-1 monoclonal antibodies.